Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Glenn Saldanha of...

    Glenn Saldanha of Glenmark appointed IPA President

    Written by Ruby Khatun Khatun Published On 2017-10-19T10:05:51+05:30  |  Updated On 19 Oct 2017 10:05 AM IST
    Glenn Saldanha of Glenmark appointed IPA President

    New Delhi: Indian Pharmaceutical Alliance (IPA), a body of major domestic pharma firms, said Glenn Saldanha has been appointed as President for 2017-19.


    Saldanha is Chairman & Managing Director of Glenmark Pharmaceuticals.


    IPA also appointed Panacea Biotec Joint Managing Director Rajesh Jain as Vice President.


    The IPA, initially formed by eight national companies in November 1999, has now 20 research-based national pharmaceutical companies in its fold.


    Some of the prominent members include Lupin, Cadila Healthcare, Cipla, Dr. Reddy's Laboratories and Sun Pharmaceutical Industries among others.

    appointedCadila HealthcareCiplaDr Reddy's LaboratoriesFosun PharmaceuticalGlenmarkGlenmark PharmaceuticalsGlenn Saldanhaindian pharma newsIndian Pharmaceutical AllianceIPA PresidentLupinPanacea Biotecpharma newspharma news indiaRajesh JainVice President
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok